The device combines the osseointegration properties of the OXPEKK material and VySpine’s OsteoVy lattice structure. It is indicated for treating degenerative disc disease.
PEKK implants don’t have any radiographic interference, no fibrotic tissue membrane formation and show increased bony apposition and higher push-out strength compared to PEEK implants.
“The ClariVy OsteoVy PEKK clearance is the first in a long line of Vy Spine implants which will utilize the unique qualities of our proprietary OsteoVy PEKK designs,” Brett Berry, president of product development at VySpine, said in the release. “As we researched OXPEKK and its unique characteristics, we began to realize that its composition accomplishes what we as an industry had always hoped PEEK would accomplish. But PEEK fell short. We are very excited about the OXPEKK material and our partnership with Oxford Performance Materials to make this new device possible.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
